antibody

P16-INK4A Rabbit Polyclonal

FNab06064

100 ug

polyclonal

domestic rabbit

nonconjugated

western blot, ELISA, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry

P16-INK4A Rabbit Polyclonal

Antibody

Rabbit

Polyclonal

Unconjugated

IgG

100 ug

CDKN2A generates several transcript variants which differ in their first exons. At least three alternatively-spliced variants encoding distinct proteins have been reported, and two are related, named p16-INK4 and p14 respetively, sharing 50% identity. The third one is completely stuctually un-related, called p14(ARF) or p19(ARF). 10883-1-AP reacted with p16 specifically. P16 plays an important role in regulating the cell cycle, and mutations in p16 increase the risk of developing a variety of cancers, notably melanoma.

ARF antibody,CDKN2A antibody, CDK4 inhibitor p16 INK4 antibody, CDK4 inhibitor p16INK4 antibody, CDK4I antibody, CDKN2 antibody, CDKN2A antibody, CMM2 antibody, INK4 antibody, INK4a antibody, MLM antibody, MTS 1 antibody, MTS1 antibody, Multiple tumor suppressor 1 antibody, p14 antibody, p14ARF antibody, P16 antibody, p16 INK4 antibody, p16 INK4a antibody, p16INK4 antibody, p16INK4a antibody, P19 antibody, TP16 antibody,P16-INK4A Antibody

P16-INK4A antibody: Rabbit Polyclonal antibody to P16-INK4A

cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)

Human, Mouse ,Rat

≥95% as determined by SDS-PAGE

ELISA, WB, IF, IP, IHC, FC

PBS with 0.02% sodium azide and 50% glycerol pH 7.3 , -20℃ for 24 months (Avoid repeated freeze / thaw cycles.)